Enakshi D Sunassee

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Emergency Department

Breast Cancer Cells

Chemotherapy Induced

Top Venues

Science advances

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Riley J Deutsch, Victoria W D'Agostino, Pol Castellano-Escuder, Elizabeth A Siebeneck, Olga R Ilkayeva, Brian T Crouch, Megan C Madonna, Jeffrey I Everitt, James V Alvarez, Gregory M Palmer, Matthew D Hirschey, Nirmala Ramanujam
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence. Science advances 10 (14) (2024)
Enakshi D Sunassee, Bruna Victorasso Jardim-Perassi, Megan C Madonna, Bryce Ordway, Nirmala Ramanujam
Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC). Molecular cancer research : MCR (2023)